Polycystic Ovarian Syndrome in Adolescents: From Diagnostic Criteria to Therapeutic Management

Overview

Journal Acta Biomed

Specialty General Medicine

Date 2020 Sep 14

PMID 32921781

Citations 4

Authors

Nicolas C Nicolaides

Andreas Matheou

Florentia Vlachou

Vassos Neocleous

Nicos Skordis

Affiliations

Soon will be listed here.

Abstract

Polycystic ovarian syndrome is a common endocrinologic condition diagnosed in women of childbearing age. It is primarily associated with androgen excess and ovarian dysfunction, which contribute to menstrual irregularity, oligo-anovulation, infertility, hirsutism and acne. It is associated with several systemic conditions, including type 2 diabetes mellitus, cardiovascular disease, obesity and neuropsychological disorders. The exact pathophysiology and clinical features are highly variable and, thus, there is still controversy in defining the diagnostic criteria. In this review, we outline the main diagnostic criteria, discuss the mechanisms involved in the complex pathogenesis, and present the associated clinical manifestations and therapeutic management of the syndrome in adolescents.

Citing Articles

Dairy consumption and its association with anthropometric measurements, blood glucose status, insulin levels, and testosterone levels in women with polycystic ovary syndrome: a comprehensive systematic review and meta-analysis.

Rastad H, Shahrestanaki E, Heydarian H, Maarefvand M Front Endocrinol (Lausanne). 2024; 15:1334496.

PMID: 39421532 PMC: 11484274. DOI: 10.3389/fendo.2024.1334496.

Polycystic Ovary Syndrome: A Comprehensive Exploration of Diagnosis Experience in Saudi Women.

Alqntash N, AlZabin A, Almajed E, Alotaibi K, Alhindi G, Ali S J Clin Med. 2024; 13(17).

PMID: 39274518 PMC: 11395902. DOI: 10.3390/jcm13175305.

Criteria for Diagnosis of Polycystic Ovary Syndrome during Adolescence: Literature Review.

Pena A, Codner E, Witchel S Diagnostics (Basel). 2022; 12(8).

PMID: 36010282 PMC: 9406411. DOI: 10.3390/diagnostics12081931.

An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options.

Islam H, Masud J, Islam Y, Haque F Womens Health (Lond). 2022; 18:17455057221117966.

PMID: 35972046 PMC: 9386861. DOI: 10.1177/17455057221117966.

References

Ibanez L, Valls C, Potau N, Marcos M, de Zegher F . Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect. Clin Endocrinol (Oxf). 2002; 55(5):667-72. DOI: 10.1046/j.1365-2265.2001.01399.x. View

Fernandez M, Bourguignon N, Lux-Lantos V, Libertun C . Neonatal exposure to bisphenol a and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats. Environ Health Perspect. 2010; 118(9):1217-22. PMC: 2944080. DOI: 10.1289/ehp.0901257. View

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale H, Futterweit W . Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006; 91(11):4237-45. DOI: 10.1210/jc.2006-0178. View

Sirmans S, Pate K . Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2014; 6:1-13. PMC: 3872139. DOI: 10.2147/CLEP.S37559. View

Amiel S, Sherwin R, Simonson D, Lauritano A, Tamborlane W . Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med. 1986; 315(4):215-9. DOI: 10.1056/NEJM198607243150402. View

Wang R, Mol B . The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?. Hum Reprod. 2017; 32(2):261-264. DOI: 10.1093/humrep/dew287. View

Tucker L, Erickson A, Lecheminant J, Bailey B . Dairy consumption and insulin resistance: the role of body fat, physical activity, and energy intake. J Diabetes Res. 2015; 2015:206959. PMC: 4325471. DOI: 10.1155/2015/206959. View

Skordis N, Shammas C, Phedonos A, Kyriakou A, Toumba M, Neocleous V . Genetic defects of the CYP21A2 gene in girls with premature adrenarche. J Endocrinol Invest. 2014; 38(5):535-9. DOI: 10.1007/s40618-014-0223-1. View

Bridges N, Cooke A, Healy M, Hindmarsh P, Brook C . Standards for ovarian volume in childhood and puberty. Fertil Steril. 1993; 60(3):456-60. View

10.

Hogeveen K, Cousin P, Pugeat M, Dewailly D, Soudan B, Hammond G . Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction. J Clin Invest. 2002; 109(7):973-81. PMC: 150924. DOI: 10.1172/JCI14060. View

11.

Gacaferri Lumezi B, Berisha V, Pupovci H, Goci A, Hajrushi A . Grading of hirsutism based on the Ferriman-Gallwey scoring system in Kosovar women. Postepy Dermatol Alergol. 2019; 35(6):631-635. PMC: 6320479. DOI: 10.5114/ada.2018.77615. View

12.

Dumesic D, Oberfield S, Stener-Victorin E, Marshall J, Laven J, Legro R . Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015; 36(5):487-525. PMC: 4591526. DOI: 10.1210/er.2015-1018. View

13.

Ibanez L, Oberfield S, Witchel S, Auchus R, Chang R, Codner E . An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Horm Res Paediatr. 2017; 88(6):371-395. DOI: 10.1159/000479371. View

14.

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale H, Futterweit W . The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2008; 91(2):456-88. DOI: 10.1016/j.fertnstert.2008.06.035. View

15.

Settas N, Dracopoulou-Vabouli M, Dastamani A, Katsikis I, Chrousos G, Panidis D . CYP21A2 mutations in women with polycystic ovary syndrome (PCOS). Horm Metab Res. 2013; 45(5):383-6. DOI: 10.1055/s-0033-1333727. View

16.

Neocleous V, Shammas C, Phedonos A, Phylactou L, Skordis N . Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations. Indian J Endocrinol Metab. 2014; 18(Suppl 1):S72-9. PMC: 4266872. DOI: 10.4103/2230-8210.145077. View

17.

Vigorito C, Giallauria F, Palomba S, Cascella T, Manguso F, Lucci R . Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007; 92(4):1379-84. DOI: 10.1210/jc.2006-2794. View

18.

Escobar-Morreale H . Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018; 14(5):270-284. DOI: 10.1038/nrendo.2018.24. View

19.

Thompson I, Kaiser U . GnRH pulse frequency-dependent differential regulation of LH and FSH gene expression. Mol Cell Endocrinol. 2013; 385(1-2):28-35. PMC: 3947649. DOI: 10.1016/j.mce.2013.09.012. View

20.

Hueb C, Dias Junior J, Abrao M, Filho E . Drilling: medical indications and surgical technique. Rev Assoc Med Bras (1992). 2016; 61(6):530-5. DOI: 10.1590/1806-9282.61.06.530. View